CCXI logo

ChemoCentryx (CCXI) Depreciation And Amortization

Annual D&A

$3.14 M
+$2.34 M+293.85%

December 31, 2021

Summary

Performance

1-Year Change

+293.85%

3-Year Change

+513.09%

5-Year Change

+650.96%

15-Year Change

+650.96%

CCXI Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.14 M
CCXI annual depreciation & amortization is currently at an all-time high

3-Year Low

$3.14 M
CCXI annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CCXI previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CCXI next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$161.82 M
CCXI annual total expenses is $161.82 million

Annual Operating Expenses

$161.52 M
CCXI annual total operating expenses is $161.52 million

Annual Cost Of Goods Sold

$302.00 K
CCXI annual cost of goods sold is $302.00 thousand

Annual Interest Expense

$2.69 M
CCXI annual interest expense is $2.69 million

Quarterly D&A

$1.02 M
+$7000.00+0.69%

June 30, 2022

Summary

Performance

3-Month Change

+0.69%

1-Year Change

+2.09%

3-Year Change

+144.39%

5-Year Change

+875.24%

CCXI Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.02 M
CCXI quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$1.02 M
CCXI quarterly depreciation & amortization is currently +0.79% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$43.34 M
CCXI quarterly total expenses is $43.34 million

Quarterly Operating Expenses

$42.53 M
CCXI quarterly total operating expenses is $42.53 million

Quarterly Cost Of Goods Sold

$803.00 K
CCXI quarterly cost of goods sold is $803.00 thousand

Quarterly Interest Expense

$586.00 K
CCXI quarterly interest expense is $586.00 thousand

TTM D&A

$4.06 M
+$21.00 K+0.52%

June 30, 2022

Summary

Performance

3-Month Change

+0.52%

1-Year Change

+147.26%

3-Year Change

+638.18%

5-Year Change

+638.18%

CCXI TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.06 M
CCXI TTM depreciation & amortization is currently at an all-time high

3-Year Low

$3.14 M
CCXI TTM depreciation & amortization is currently +29.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$161.82 M
CCXI annual total expenses is $161.82 million

Annual Operating Expenses

$161.52 M
CCXI annual total operating expenses is $161.52 million

TTM Cost Of Goods Sold

$1.01 M
CCXI TTM cost of goods sold is $1.01 million

TTM Interest Expense

$2.49 M
CCXI TTM interest expense is $2.49 million

CCXI Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+293.9%+2.1%+147.3%
3 y3 years+513.1%+144.4%+638.2%
5 y5 years+651.0%+875.2%+638.2%

CCXI Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-0.8%at high-22.7%
5 y5-yearat high-82.5%at high-88.6%at high-99.4%
alltimeall timeat high-88.9%at high-137.7%at high-99.4%

ChemoCentryx Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2022
-
$1.02 M(+0.7%)
$4.06 M(+0.5%)
Mar 2022
-
$1.02 M(+0.1%)
$4.04 M(+28.7%)
Dec 2021
$3.14 M(+293.9%)
$1.02 M(+1.3%)
$3.14 M(+24.7%)
Sep 2021
-
$1.00 M(0.0%)
$2.52 M(+53.3%)
Jun 2021
-
$1.00 M(+757.3%)
$1.64 M(+113.0%)
Mar 2021
-
$117.00 K(-70.4%)
$771.00 K(-3.3%)
Dec 2020
$797.00 K(+44.9%)
$395.00 K(+211.0%)
$797.00 K(+47.9%)
Sep 2020
-
$127.00 K(-3.8%)
$539.00 K(+1973.1%)
Jun 2020
-
$132.00 K(-7.7%)
$26.00 K(-91.7%)
Mar 2020
-
$143.00 K(+4.4%)
$313.00 K(-43.1%)
Dec 2019
$550.00 K(+7.4%)
$137.00 K(-135.5%)
$550.00 K(-0.7%)
Sep 2019
-
-$386.00 K(-192.1%)
$554.00 K(-48.9%)
Jun 2019
-
$419.00 K(+10.3%)
$1.08 M(+38.8%)
Mar 2019
-
$380.00 K(+169.5%)
$781.00 K(+52.5%)
Dec 2018
$512.00 K(+22.5%)
$141.00 K(-2.1%)
$512.00 K(+7.1%)
Sep 2018
-
$144.00 K(+24.1%)
$478.00 K(+8.1%)
Jun 2018
-
$116.00 K(+4.5%)
$442.00 K(+2.6%)
Mar 2018
-
$111.00 K(+3.7%)
$431.00 K(+3.1%)
Dec 2017
$418.00 K(+20.1%)
$107.00 K(-0.9%)
$418.00 K(+4.8%)
Sep 2017
-
$108.00 K(+2.9%)
$399.00 K(+5.6%)
Jun 2017
-
$105.00 K(+7.1%)
$378.00 K(+5.0%)
Mar 2017
-
$98.00 K(+11.4%)
$360.00 K(+3.4%)
Dec 2016
$348.00 K
$88.00 K(+1.1%)
$348.00 K(-3.9%)
Sep 2016
-
$87.00 K(0.0%)
$362.00 K(-7.4%)
DateAnnualQuarterlyTTM
Jun 2016
-
$87.00 K(+1.2%)
$391.00 K(-9.1%)
Mar 2016
-
$86.00 K(-15.7%)
$430.00 K(-9.9%)
Dec 2015
$477.00 K(-12.2%)
$102.00 K(-12.1%)
$477.00 K(-5.4%)
Sep 2015
-
$116.00 K(-7.9%)
$504.00 K(-2.5%)
Jun 2015
-
$126.00 K(-5.3%)
$517.00 K(-1.1%)
Mar 2015
-
$133.00 K(+3.1%)
$523.00 K(-3.7%)
Dec 2014
$543.00 K(-5.7%)
$129.00 K(0.0%)
$543.00 K(-3.7%)
Sep 2014
-
$129.00 K(-2.3%)
$564.00 K(-2.4%)
Jun 2014
-
$132.00 K(-13.7%)
$578.00 K(-1.5%)
Mar 2014
-
$153.00 K(+2.0%)
$587.00 K(+1.9%)
Dec 2013
$576.00 K(-2.7%)
$150.00 K(+4.9%)
$576.00 K(+2.5%)
Sep 2013
-
$143.00 K(+1.4%)
$562.00 K(-0.4%)
Jun 2013
-
$141.00 K(-0.7%)
$564.00 K(-1.9%)
Mar 2013
-
$142.00 K(+4.4%)
$575.00 K(-2.9%)
Dec 2012
$592.00 K(-21.5%)
$136.00 K(-6.2%)
$592.00 K(-7.6%)
Sep 2012
-
$145.00 K(-4.6%)
$641.00 K(-6.4%)
Jun 2012
-
$152.00 K(-4.4%)
$685.00 K(-5.4%)
Mar 2012
-
$159.00 K(-14.1%)
$724.00 K(-4.0%)
Dec 2011
$754.00 K(+14.2%)
$185.00 K(-2.1%)
$754.00 K(+32.5%)
Sep 2011
-
$189.00 K(-1.0%)
$569.00 K(+49.7%)
Jun 2011
-
$191.00 K(+1.1%)
$380.00 K(+101.1%)
Mar 2011
-
$189.00 K
$189.00 K
Dec 2010
$660.00 K(-7.4%)
-
-
Dec 2009
$713.00 K(+0.8%)
-
-
Dec 2008
$707.00 K
-
-

FAQ

  • What is ChemoCentryx annual depreciation & amortization?
  • What is the all time high annual D&A for ChemoCentryx?
  • What is ChemoCentryx annual D&A year-on-year change?
  • What is ChemoCentryx quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for ChemoCentryx?
  • What is ChemoCentryx quarterly D&A year-on-year change?
  • What is ChemoCentryx TTM depreciation & amortization?
  • What is the all time high TTM D&A for ChemoCentryx?
  • What is ChemoCentryx TTM D&A year-on-year change?

What is ChemoCentryx annual depreciation & amortization?

The current annual D&A of CCXI is $3.14 M

What is the all time high annual D&A for ChemoCentryx?

ChemoCentryx all-time high annual depreciation & amortization is $3.14 M

What is ChemoCentryx annual D&A year-on-year change?

Over the past year, CCXI annual depreciation & amortization has changed by +$2.34 M (+293.85%)

What is ChemoCentryx quarterly depreciation & amortization?

The current quarterly D&A of CCXI is $1.02 M

What is the all time high quarterly D&A for ChemoCentryx?

ChemoCentryx all-time high quarterly depreciation & amortization is $1.02 M

What is ChemoCentryx quarterly D&A year-on-year change?

Over the past year, CCXI quarterly depreciation & amortization has changed by +$21.00 K (+2.09%)

What is ChemoCentryx TTM depreciation & amortization?

The current TTM D&A of CCXI is $4.06 M

What is the all time high TTM D&A for ChemoCentryx?

ChemoCentryx all-time high TTM depreciation & amortization is $4.06 M

What is ChemoCentryx TTM D&A year-on-year change?

Over the past year, CCXI TTM depreciation & amortization has changed by +$2.42 M (+147.26%)